|
⚲
|
| Keyboard |
| MacFarlane M David
✚
|
|
|---|---|
| CIK # | 0001182314 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001182314] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| MacFarlane M David | |
| Titan Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Titan Pharmaceuticals Inc TTNP.OB
Option to Purchase Common Stock · derivative
|
2022-01-05 | Grant | 10,000 | $0.00 | |
|
Titan Pharmaceuticals Inc TTNP.OB
Option to Purchase Common Stock · derivative
|
2021-02-10 | Grant | 25,000 | $0.00 | |
|
Titan Pharmaceuticals Inc TTNP.OB
Warrants · derivative
|
2018-09-21 | Grant | 80,000 | $0.00 | |
|
Titan Pharmaceuticals Inc TTNP.OB
Common Stock
|
2018-09-21 | Buy | 80,000 | $0.25 | 20,000 |
|
Titan Pharmaceuticals Inc TTNP
Option to Purchase Common Stock · derivative
|
2017-09-15 | Grant | 10,000 | $0.00 | |
|
Titan Pharmaceuticals Inc TTNP
Option to Purchase Common Stock · derivative
|
2017-02-16 | Grant | 10,000 | $0.00 | |
|
Titan Pharmaceuticals Inc TTNP.OB
Option to Purchase Common Stock · derivative
|
2015-12-14 | Grant | 10,000 | $0.00 | |
|
Titan Pharmaceuticals Inc TTNP.OB
Option to Purchase Common Stock · derivative
|
2015-03-16 | Grant | 25,000 | $0.00 | |
|
Titan Pharmaceuticals Inc TTNP.OB
Option to Purchase Common Stock · derivative
|
2014-02-12 | Grant | 25,000 | $0.00 | |
|
Titan Pharmaceuticals Inc TTNP.OB
Option to Purchase Common Stock · derivative
|
2012-01-03 | Grant | 30,000 | $0.00 |